{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:46:43Z","timestamp":1793252803766,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jss.2013.04.042","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T15:03:19Z","timestamp":1368284599000},"page":"519-525","source":"Crossref","is-referenced-by-count":13,"title":["High TFAP2C\/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer"],"prefix":"10.1016","volume":"184","author":[{"given":"Philip M.","family":"Spanheimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan W.","family":"Askeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail V.","family":"Kulak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2013.04.042_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2013.04.042_bib2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1245\/s10434-011-2108-2","article-title":"Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer","volume":"19","author":"Kaufmann","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2013.04.042_bib3","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","article-title":"The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"21","author":"Bear","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2013.04.042_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.1995.13.3.547","article-title":"Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer","volume":"13","author":"Powles","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2013.04.042_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/07357909809039761","article-title":"The efficacy of neoadjuvant chemotherapy compared to postoperative therapy in the treatment of locally advanced breast cancer","volume":"16","author":"Cunningham","year":"1998","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jss.2013.04.042_bib6","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2013.04.042_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00000658-200209000-00006","article-title":"Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival","volume":"236","author":"Cance","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2013.04.042_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1200\/JCO.1998.16.1.93","article-title":"Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute","volume":"16","author":"Bonadonna","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2013.04.042_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2012.10.025","article-title":"The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer","author":"Spanheimer","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.jss.2013.04.042_bib10","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1245\/s10434-011-1665-8","article-title":"Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer","volume":"18","author":"Meyers","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2013.04.042_bib11","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy","volume":"11","author":"Rouzier","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2013.04.042_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1245\/s10434-011-1877-y","article-title":"Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response","volume":"19","author":"Fisher","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2013.04.042_bib13","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1158\/0008-5472.CAN-07-2293","article-title":"TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling","volume":"67","author":"Woodfield","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2013.04.042_bib14","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1158\/1078-0432.CCR-08-2343","article-title":"Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure","volume":"15","author":"Woodfield","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2013.04.042_bib15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/gcc.20807","article-title":"Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells","volume":"49","author":"Woodfield","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jss.2013.04.042_bib16","article-title":"Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor","author":"Spanheimer","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2013.04.042_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10549-011-1775-9","article-title":"The rearranged during transfection\/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells","volume":"133","author":"Wang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2013.04.042_bib18","article-title":"Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer","author":"Kulak","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jss.2013.04.042_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/path.2430","article-title":"Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival","volume":"217","author":"Gee","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.jss.2013.04.042_bib20","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1093\/nar\/27.20.4040","article-title":"AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs","volume":"27","author":"McPherson","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jss.2013.04.042_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/bcr2111","article-title":"Breast cancer stem cells: implications for therapy of breast cancer","volume":"10","author":"Morrison","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jss.2013.04.042_bib22","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"10.1016\/j.jss.2013.04.042_bib23","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1479-5876-10-S1-S6","article-title":"Relationship of CD44+CD24-\/low breast cancer stem cells and axillary lymph node metastasis","volume":"10","author":"Wei","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.jss.2013.04.042_bib24","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/bjc.2011.159","article-title":"An increase in cancer stem cell\u00a0population after primary systemic therapy is a poor prognostic factor in breast cancer","volume":"104","author":"Lee","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jss.2013.04.042_bib25","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1158\/0008-5472.CAN-07-5100","article-title":"The Ret receptor tyrosine kinase pathway functionally interacts with the\u00a0ERalpha pathway in breast cancer","volume":"68","author":"Boulay","year":"2008","journal-title":"Cancer Res"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480413004174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480413004174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T22:52:34Z","timestamp":1539643954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480413004174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0022480413004174"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2013.04.042","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}